[go: up one dir, main page]

GB2368013B - An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain - Google Patents

An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Info

Publication number
GB2368013B
GB2368013B GB0104012A GB0104012A GB2368013B GB 2368013 B GB2368013 B GB 2368013B GB 0104012 A GB0104012 A GB 0104012A GB 0104012 A GB0104012 A GB 0104012A GB 2368013 B GB2368013 B GB 2368013B
Authority
GB
United Kingdom
Prior art keywords
pain
active ingredients
pharmacologically active
comprise multiple
antacid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0104012A
Other versions
GB0104012D0 (en
GB2368013A (en
Inventor
Richard Orlando Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0104012A priority Critical patent/GB2368013B/en
Publication of GB0104012D0 publication Critical patent/GB0104012D0/en
Publication of GB2368013A publication Critical patent/GB2368013A/en
Application granted granted Critical
Publication of GB2368013B publication Critical patent/GB2368013B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB0104012A 2001-02-19 2001-02-19 An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain Expired - Fee Related GB2368013B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0104012A GB2368013B (en) 2001-02-19 2001-02-19 An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0104012A GB2368013B (en) 2001-02-19 2001-02-19 An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Publications (3)

Publication Number Publication Date
GB0104012D0 GB0104012D0 (en) 2001-04-04
GB2368013A GB2368013A (en) 2002-04-24
GB2368013B true GB2368013B (en) 2004-07-28

Family

ID=9909016

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0104012A Expired - Fee Related GB2368013B (en) 2001-02-19 2001-02-19 An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Country Status (1)

Country Link
GB (1) GB2368013B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2302251A1 (en) 1997-09-17 1999-03-25 Eisai Co., Ltd. Antimicrobial agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2349570A (en) * 1999-05-05 2000-11-08 Reckitt & Colmann Prod Ltd Compositions for treatment of disorders of the oesophagus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2349570A (en) * 1999-05-05 2000-11-08 Reckitt & Colmann Prod Ltd Compositions for treatment of disorders of the oesophagus

Also Published As

Publication number Publication date
GB0104012D0 (en) 2001-04-04
GB2368013A (en) 2002-04-24

Similar Documents

Publication Publication Date Title
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2002210952A1 (en) Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist
AU2002301259A1 (en) Simethicone solid oral dosage form
HUP0101694A3 (en) Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists
EP1461044A4 (en) Pharmaceutical compositions comprising active vitamin d compounds
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
EP1337249A4 (en) Compositions and methods for administration of pharmacologically active compounds
ZA200207755B (en) Simethicone solid oral dosage form.
HUP0105089A3 (en) Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
AU2001236457A1 (en) Compounds and compositions for delivering active agents
EP1446103A4 (en) Injectable compositions for the controlled delivery of pharmacologically active compound
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU2001288277A1 (en) Compounds and compositions for delivering active agents
HUP0500638A3 (en) Flashmelt oral dosage formulation
AP2004003045A0 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same.
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU2002340573A8 (en) Powdery active ingredient formulations
EP1407780A4 (en) Pharmaceutically stable hemostatic compositions
GB0107751D0 (en) Pharmaceutically active compounds
AU2002316200A1 (en) Compound and composition for delivering active agents
GB0106631D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
AU2002346569A8 (en) Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
GB2368013B (en) An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060219